Impact of Cannabidiol and Exercise on Clinical Outcomes and Gut Microbiota for Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors: A Case Report

• Main Authors: MariaLuisa Vigano (Author), Sarah Kubal (Author), Yao Lu (Author), Sarah Habib (Author), Suzanne Samarani (Author), Georgina Cama (Author), Charles Viau (Author), Houman Farzin (Author), Nebras Koudieh (Author), Jianguo Xia (Author), Ali Ahmad (Author), Antonio Vigano (Author), Cecilia T. Costiniuk (Author)
• Format: Book
• Published: MDPI AG, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Chemotherapy-induced peripheral neuropathy (CIPN) remains a clinical challenge for up to 80% of breast cancer survivors. In an open-label study, participants underwent three interventions: standard care (duloxetine) for 1 month (Phase 1), oral cannabidiol (CBD) for 2 months (Phase 2), and CBD plus m...